These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23875707)

  • 1. Comparison of genotypic and phenotypic HIV type 1 tropism assay: results from the screening samples of Cenicriviroc Study 202, a randomized phase II trial in treatment-naive subjects.
    Kagan RM; Johnson EP; Siaw MF; Van Baelen B; Ogden R; Platt JL; Pesano RL; Lefebvre E
    AIDS Res Hum Retroviruses; 2014 Feb; 30(2):151-9. PubMed ID: 23875707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A genotypic test for HIV-1 tropism combining Sanger sequencing with ultradeep sequencing predicts virologic response in treatment-experienced patients.
    Kagan RM; Johnson EP; Siaw M; Biswas P; Chapman DS; Su Z; Platt JL; Pesano RL
    PLoS One; 2012; 7(9):e46334. PubMed ID: 23029482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between genotypic (V3 population sequencing) and phenotypic (Trofile ES) methods of characterizing co-receptor usage of HIV-1 from 200 treatment-naïve HIV patients screened for Study A4001078.
    Portsmouth S; Valluri SR; Däumer M; Thiele B; Valdez H; Lewis M; Craig C; Thielen A; James I; Demarest J; Heera J
    Antiviral Res; 2013 Jan; 97(1):60-5. PubMed ID: 23165088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of commonly used genotypic assays and comparison with phenotypic assays of HIV-1 coreceptor tropism in acutely HIV-1-infected patients.
    Ceresola ER; Nozza S; Sampaolo M; Pignataro AR; Saita D; Ferrarese R; Ripa M; Deng W; Mullins JI; Boeri E; Tambussi G; Toniolo A; Lazzarin A; Clementi M; Canducci F
    J Antimicrob Chemother; 2015 May; 70(5):1391-5. PubMed ID: 25608585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of genotypic algorithms for predicting HIV-1 tropism measured against the enhanced-sensitivity Trofile coreceptor tropism assay.
    Sánchez V; Masiá M; Robledano C; Padilla S; Ramos JM; Gutiérrez F
    J Clin Microbiol; 2010 Nov; 48(11):4135-9. PubMed ID: 20861336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coreceptor Tropism and Maraviroc Sensitivity of Clonally Derived Ethiopian HIV-1C Strains Using an in-house Phenotypic Assay and Commonly Used Genotypic Methods.
    Kalu AW; Telele NF; Aralaguppe SG; Gebre-Selassie S; Fekade D; Marrone G; Sonnerborg A
    Curr HIV Res; 2018; 16(2):113-120. PubMed ID: 29766813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High concordance of genotypic coreceptor prediction in plasma-viral RNA and proviral DNA of HIV-1 subtype C: implications for use of whole blood DNA in resource-limited settings.
    Gupta S; Neogi U; Srinivasa H; Shet A
    J Antimicrob Chemother; 2013 Sep; 68(9):2003-6. PubMed ID: 23633683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA.
    Swenson LC; Moores A; Low AJ; Thielen A; Dong W; Woods C; Jensen MA; Wynhoven B; Chan D; Glascock C; Harrigan PR
    J Acquir Immune Defic Syndr; 2010 Aug; 54(5):506-10. PubMed ID: 20512044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitive cell-based assay for determination of human immunodeficiency virus type 1 coreceptor tropism.
    Weber J; Vazquez AC; Winner D; Gibson RM; Rhea AM; Rose JD; Wylie D; Henry K; Wright A; King K; Archer J; Poveda E; Soriano V; Robertson DL; Olivo PD; Arts EJ; Quiñones-Mateu ME
    J Clin Microbiol; 2013 May; 51(5):1517-27. PubMed ID: 23486708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients.
    Swenson LC; Mo T; Dong WW; Zhong X; Woods CK; Jensen MA; Thielen A; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    J Infect Dis; 2011 Jan; 203(2):237-45. PubMed ID: 21288824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concordance between two phenotypic assays and ultradeep pyrosequencing for determining HIV-1 tropism.
    Saliou A; Delobel P; Dubois M; Nicot F; Raymond S; Calvez V; Masquelier B; Izopet J;
    Antimicrob Agents Chemother; 2011 Jun; 55(6):2831-6. PubMed ID: 21464245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-based V3 genotypic tropism assay: a retrospective analysis using screening samples from the A4001029 and MOTIVATE studies.
    McGovern RA; Thielen A; Mo T; Dong W; Woods CK; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    AIDS; 2010 Oct; 24(16):2517-25. PubMed ID: 20736814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro.
    Svicher V; Balestra E; Cento V; Sarmati L; Dori L; Vandenbroucke I; D'Arrigo R; Buonomini AR; Van Marck H; Surdo M; Saccomandi P; Mostmans W; Aerssens J; Aquaro S; Stuyver LJ; Andreoni M; Ceccherini-Silberstein F; Perno CF
    Antiviral Res; 2011 Apr; 90(1):42-53. PubMed ID: 21349294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population-based sequencing of the V3-loop can predict the virological response to maraviroc in treatment-naive patients of the MERIT trial.
    McGovern RA; Thielen A; Portsmouth S; Mo T; Dong W; Woods CK; Zhong X; Brumme CJ; Chapman D; Lewis M; James I; Heera J; Valdez H; Harrigan PR
    J Acquir Immune Defic Syndr; 2012 Nov; 61(3):279-86. PubMed ID: 23095934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping.
    Prosperi MC; Bracciale L; Fabbiani M; Di Giambenedetto S; Razzolini F; Meini G; Colafigli M; Marzocchetti A; Cauda R; Zazzi M; De Luca A
    Retrovirology; 2010 Jun; 7():56. PubMed ID: 20591141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep-Sequencing Analysis of the Dynamics of HIV-1 Quasiespecies in Naive Patients during a Short Exposure to Maraviroc.
    Cascajero A; Rastrojo A; Díez-Fuertes F; Hernández-Novoa B; Aguado B; Moreno S; Alcami J; Pérez-Olmeda M
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitivity of specific genotypic tools for detection of X4 variants in antiretroviral-experienced patients suitable to be treated with CCR5 antagonists.
    Seclén E; Garrido C; González Mdel M; González-Lahoz J; de Mendoza C; Soriano V; Poveda E
    J Antimicrob Chemother; 2010 Jul; 65(7):1486-92. PubMed ID: 20427374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice.
    Symons J; Vandekerckhove L; Paredes R; Verhofstede C; Bellido R; Demecheleer E; van Ham PM; van Lelyveld SF; Stam AJ; van Versendaal D; Nijhuis M; Wensing AM
    Clin Microbiol Infect; 2012 Jun; 18(6):606-12. PubMed ID: 21906210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evolution of HIV-1 quasispecies and coreceptor use in cell reservoirs of patients on suppressive antiretroviral therapy.
    Raymond S; Saliou A; Delobel P; Cazabat M; Pasquier C; Jeanne N; Sauné K; Massip P; Marchou B; Izopet J
    J Antimicrob Chemother; 2014 Sep; 69(9):2527-30. PubMed ID: 24840625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.